Geron Corporation (NASDAQ: GERN) is 16.91% higher on its value in year-to-date trading and has touched a low of $0.75 and a high of $2.40 in the current 52-week trading range. The GERN stock was last observed hovering at around $1.59 in the last trading session, with the day’s loss setting it 0.0% off its average median price target of $3.50 for the next 12 months. It is also 77.29% off the consensus price target high of $7.00 offered by 6 analysts, but current levels are 47.0% higher than the price target low of $3.00 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Currently trading at $1.59, the stock is -6.29% and -11.20% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.41 million and changing 0.00% at the moment leaves the stock -6.01% off its SMA200. GERN registered 19.55% gain for a year compared to 6-month loss of -26.73%. The firm has a 50-day simple moving average (SMA 50) of $1.7556 and a 200-day simple moving average (SMA200) of $1.8449.
The stock witnessed a -13.59% gain in the last 1 month and extending the period to 3 months gives it a -10.17%, and is -5.36% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.22% over the week and 4.39% over the month.
Geron Corporation (GERN) has around 45 employees, a market worth around $493.70M and $0.40M in sales. Distance from 52-week low is 112.00% and -33.75% from its 52-week high. The company has generated returns on investments over the last 12 months (-53.60%).
Geron Corporation (GERN) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Geron Corporation (GERN) is a “Buy”. 6 analysts offering their recommendations for the stock have an average rating of 1.70, where 0 rate it as a Hold and 0 think it is a “Overweight”. 6 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Geron Corporation is expected to release its quarterly report on 05/06/2021 and quarterly earnings per share for the current quarter are estimated at -$0.06 with sales reaching $70k over the same period.The EPS is expected to shrink by -135.50% this year, but quarterly earnings will post -43.50% year-over-year. Quarterly sales are estimated to shrink -59.10% in year-over-year returns.
Geron Corporation (GERN) Top Institutional Holders
203 institutions hold shares in Geron Corporation (GERN), with 506.07k shares held by insiders accounting for 0.16% while institutional investors hold 56.29% of the company’s shares. The shares outstanding are 318.80M, and float is at 296.50M with Short Float at 16.72%. Institutions hold 56.20% of the Float.
The top institutional shareholder in the company is RA Capital Management, L.P. with over 30.13 million shares valued at $52.42 million. The investor’s holdings represent 9.70% of the GERN Shares outstanding. As of Sep 29, 2020, the second largest holder is Blackrock Inc. with 24.59 million shares valued at $42.78 million to account for 7.92% of the shares outstanding. The other top investors are EcoR1 Capital, LLC which holds 19.23 million shares representing 6.19% and valued at over $33.46 million, while Vanguard Group, Inc. (The) holds 5.07% of the shares totaling 15.73 million with a market value of $27.37 million.
Geron Corporation (GERN) Insider Activity
The most recent transaction is an insider purchase by O’Farrell Elizabeth G., the company’s Director. SEC filings show that O’Farrell Elizabeth G. bought 17,441 shares of the company’s common stock on Aug 21 at a price of $1.73 per share for a total of $30173.0. Following the purchase, the insider now owns 19641.0 shares.
Geron Corporation disclosed in a document filed with the SEC on Jan 10 that O’Farrell Elizabeth G. (Director) bought a total of 2,200 shares of the company’s common stock. The trade occurred on Jan 10 and was made at $1.34 per share for $2948.0. Following the transaction, the insider now directly holds 2200.0 shares of the GERN stock.
Still, SEC filings show that on Jan 10, O’Farrell Elizabeth G. (Director) acquired 800 shares at an average price of $1.35 for $1080.0. The insider now directly holds 800 shares of Geron Corporation (GERN).
Geron Corporation (GERN): Who are the competitors?
The company’s main competitors (and peers) include CTI BioPharma Corp. (CTIC) that is trading 109.09% up over the past 12 months. Incyte Corporation (INCY) is 1.17% up on the 1-year trading charts. Short interest in the company’s stock has risen 2.86% from the last report on Nov 12, 2020 to stand at a total of 48.17 million short shares sold with a short interest ratio of 21.